Abingdon Health (LSE:ABDX) Debt-to-EBITDA : -0.56 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Abingdon Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.10 Mil. Abingdon Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.91 Mil. Abingdon Health's annualized EBITDA for the quarter that ended in Dec. 2023 was £-1.80 Mil. Abingdon Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.56.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Abingdon Health's Debt-to-EBITDA or its related term are showing as below:

LSE:ABDX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.61 Med: -0.25 Max: 5.88
Current: -0.61

During the past 6 years, the highest Debt-to-EBITDA Ratio of Abingdon Health was 5.88. The lowest was -0.61. And the median was -0.25.

LSE:ABDX's Debt-to-EBITDA is ranked worse than
100% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.79 vs LSE:ABDX: -0.61

Abingdon Health Debt-to-EBITDA Historical Data

The historical data trend for Abingdon Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Debt-to-EBITDA Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.46

5.88

-0.25

-0.06

-0.36

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial					-0.13	-0.04	-0.27	-0.67	-0.56

Competitive Comparison of Abingdon Health's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Abingdon Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abingdon Health's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Debt-to-EBITDA falls into.

Abingdon Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Abingdon Health's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.087	+	0.932)	/	-2.811
	=	-0.36

Abingdon Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.097	+	0.911)	/	-1.802
	=	-0.56

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Abingdon Health (LSE:ABDX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Abingdon Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (LSE:ABDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines